Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C.
Floreani A, Antoniazzi S, Mescoli C, Bergasa NV.
Eur J Gastroenterol Hepatol. 2012 Apr;24(4):427-30.
Related citations
The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy.
Lin YM, Sheu MJ, Kuo HT, Feng IC, Sun CS, Koay LB, Lin CY.
Eur J Gastroenterol Hepatol. 2011 Nov;23(11):990-6.
A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C.
Sartori M, Andorno S, Rossini A, Boldorini R, Bozzola C, Carmagnola S, Del Piano M, Albano E.
Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1178-84.
Prevalence and risk factors of HCV infection in Poland.
Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K.
Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1213-7.
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5.
The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.
Yu JW, Sun LJ, Zhao YH, Kang P, Yan BZ.
Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1192-9.
Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):936-41.
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
Floreani A, Cazzagon N, Boemo DG, Baldovin T, Baldo V, Egoue J, Antoniazzi S, Minola E.
Eur J Gastroenterol Hepatol. 2011 Nov;23(11):997-1003.
Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe.
Urbanek P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Husa P.
Eur J Gastroenterol Hepatol. 2011 Nov;23(11):1004-10.
Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.
Tafarel JR, Tolentino LH, Correa LM, Bonilha DR, Piauilino P, Martins FP, Rodrigues RA, Nakao FS, Libera ED, Ferrari AP, da Silveira Röhr MR.
Eur J Gastroenterol Hepatol. 2011 Sep;23(9):754-8.
Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy.
Mariño Z, Carrión JA, Bedini JL, Crespo G, Martínez SM, Sánchez-Tapias JM, Forns X, Navasa MA.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):942-7.
Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse.
Shoeb D, Rowe IA, Freshwater D, Mutimer D, Brown A, Moreea S, Sood R, Marley R, Sabin CA, Foster GR.
Eur J Gastroenterol Hepatol. 2011 Sep;23(9):747-53.
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment.
Floreani A, Cazzagon N, Furlan P, Baldovin T, Egoue J, Antoniazzi S, Baldo V, Minola E.
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):711-5.
Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases.
Morin T, Pariente A, Lahmek P; Investigator Group of ANGH, SPILF, FNPRH.
Eur J Gastroenterol Hepatol. 2011 Jun;23(6):515-20.
Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
Cheung KJ, Tilleman K, Deforce D, Colle I, Moreno C, Gustot T, Van Vlierberghe H.
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):701-10.
Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Kim RD, Fujikawa T, Mizuno S, Schwartz JJ, Sorensen JB, Hemming AW, Fujita S.
Eur J Gastroenterol Hepatol. 2011 Jul;23(7):559-65.
Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.
Husa P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Urbanek P.
Eur J Gastroenterol Hepatol. 2011 May;23(5):375-81.
Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'.
Ridruejo E.
Eur J Gastroenterol Hepatol. 2011 Feb;23(2):195. No abstract available.
Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis.
Singal AK, Sagi S, Kuo YF, Weinman S.
Eur J Gastroenterol Hepatol. 2011 Mar;23(3):204-9.
Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic.
Murray MC, Barrios R, Zhang W, Hull M, Montessori V, Hogg RS, Montaner JS.
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):45-50.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on